Preparation of human-mouse heterohybridomas against an immunising antigen

Journal of Immunological Methods

Volumn 246, Issue 1-2, 2000, Pages 187-202

  Jessup, Claire F ^a   Baxendale, Helen ^b   Goldblatt, David ^b   Zola, Heddy ^a  

^a WOMEN S AND CHILDREN S HOSPITAL   (Australia)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Heterohybridoma; Pneumococcal polysaccharide; Tetanus toxoid

Indexed keywords

ADT VACCINE; ANTIGEN; BACTERIAL VACCINE; DIPHTHERIA TOXOID; INFANTRIX; MONOCLONAL ANTIBODY; PERTUSSIS TOXIN; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE; TETANUS TOXOID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; CELL FUSION; CELL IMMORTALIZATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HYBRIDOMA; IMMUNIZATION; IMMUNOCYTOCHEMISTRY; LABORATORY; LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TECHNIQUE;

ADULT; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS; CELL DIVISION; CELL FUSION; CULTURE MEDIA; HUMANS; HYBRIDOMAS; INFANT; LYMPHOCYTES; MICE; MULTIPLE MYELOMA; PNEUMOCOCCAL VACCINES; POLYETHYLENE GLYCOLS; TETANUS TOXOID;

MURINAE;

EID: 0034566064     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(00)00293-3     Document Type: Article

References (46)

1. Immunogenetic analysis of the immune response to pneumococcal polysaccharide
2. Rodent to human antibodies by CDR grafting
3. Delineation of optimal conditions for producing mouse-human heterohybridomas from human peripheral blood B cells
4. Production of human monoclonal antibodies using Epstein-Barr virus
5. Preferential retention of human chromosome 14 in mousexhuman B cell hybrids
6. DNA content and measurement for DNA ploidy and cell cycle analysis
7. Assignment of the genes for human λ immunoglobulin chains to chromosome 22
8. Restricted diversity of the variable region nucleotide sequences of the heavy and light chains of a human rheumatoid factor
9. Development of microfusion techniques to generate human hybridomas
10. Isolation of high affinity human antibodies directly from large synthetic repertoires
11. Vaccination-induced circulation of human B cells secreting type-specific antibodies against pneumococcal polysaccharides
12. Recombinant antibody constructs in cancer therapy
13. Antibacterial activity of a human monoclonal antibody to haemophilus influenzae type B capsular polysaccharide
14. In vitro immunization of human lymphocytes with human lung cancer cell line A549
15. Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children
16. A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines
17. Continuous cultures of fused cells secreting antibody of predefined specificity
18. Fusion partners for production of human monoclonal antibodies
19. Molecular analysis of rheumatoid synovial tissue: evidence for an antigen-induced stimulation with selection of high mutated IgV(H) and low mutated IgV(L/λ) genes
20. EBV transformation and microfusion as the potential source of human monoclonal antisperm antibodies
21. Human monoclonal anti-keyhole limpet hemocyanin antibody-secreting hybridoma produced from peripheral blood B lymphocytes of a keyhole limpet hemocyanin-immune individual
22. Glycosylation analysis of a polyreactive human monoclonal IgG antibody derived from a human-mouse heterohybridoma
23. Monotech patents method for human-human hybridomas
24. Antibody repertoires of four- and five-feature translocus mice carrying human immunoglobulin heavy chain and κ and λ light chain Yeast Artificial Chromosomes
25. Human-human hybridomas producing monoclonal antibodies of predefined specificity
26. Antigen-dependent regulation of IgE antibody production by human antigen-specific B cells
27. An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay
28. The genetic engineering of antibody constructs for diagnosis and therapy
29. New protein engineering approaches to multivalent and bispecific antibody fragments
30. Generation of human monoclonal antibodies reactive with human mammary carcinoma cells
31. Antibody-based immunological therapies
32. Human hybridomas and monoclonal antibodies: the biology of cell fusion
33. Cell hybridization, hybridomas, and human hybridomas
34. Human monoclonal antibodies to lung cancer antigens
35. Construction and testing of mouse-human heteromyelomas for human monoclonal antibody production
36. Strategies for production of monoclonal anti-idiotype antibodies against human B cell lymphomas
37. A human monoclonal antibody encoded by the V4-34 gene segment recognises melanoma-associated ganglioside via CDR3 and FWR1
38. Human monoclonal antibodies against blood group antigens preferentially express a VH4-21 variable region gene-associated epitope
39. Mycoplasma contamination in human leukaemia cell lines. I. Comparison of various detection methods
40. Improved fusion technique. I. Human umbilical cord serum, a new and potent growth promoter, compared with other B cell and hybridoma activators
41. Long term production of human monoclonal antibodies by human-mouse heterohybridomas
42. Generation of human monoclonal antibodies recognising membranous antigens of the lung adenocarcinoma cell line A549 using an AMeX immunostaining method
43. The effects of hybridoma growth factor in conditioned media upon the growth, cloning and antibody production of heterohybridoma cell lines
44. Efficient hybridization of mouse-human cell lines by means of hypo-osmolar electrofusion